|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.65 CNY | -0.90% |
|
+8.35% | +0.17% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 5.1% | 5.38% | 13.54x | 2.54x | 0.55x | 4.41x | 7.28x | 2.96B | |
| 2.28% | 2.57% | 16.38x | 1.71x | 0.73x | 7.64x | 9.63x | 6.04B | |
| 3.37% | 3.71% | 12.74x | 1.91x | 0.81x | 5.83x | 7.63x | 3.59B | |
| 5.81% | 6.45% | 14.23x | 4.3x | 1.21x | 7.34x | 14.24x | 3.18B | |
| 4.19% | 4.61% | 15.41x | 6.97x | 0.93x | 6.97x | 9.69x | 3.2B | |
| 1.78% | 2.15% | 23.14x | 4.05x | 0.66x | 8.51x | 13.92x | 1.7B | |
| 0.01% | -.--% | -82.32x | 2.7x | 0.44x | 16.26x | 98.3x | 1.43B | |
| 5.57% | 6.19% | 12.06x | 2.34x | 0.87x | 6.99x | 13.4x | 964M | |
| 4.72% | 5.31% | 10.76x | 0.77x | 0.25x | 2.39x | 4.93x | 849M | |
| 1.34% | 1.95% | 27.26x | 7.34x | 0.97x | 13.37x | 21.2x | 803M | |
| 0.35% | 0.37% | 14.6x | 1.97x | 0.7x | 8.53x | 13.76x | 715M | |
| -.--% | -.--% | -5.47x | 1.34x | 0.51x | -33.43x | -9.45x | 526M | |
| 1.78% | 12.84% | 7x | 0.74x | 0.23x | 3.77x | 4.52x | 513M | |
| Average | 2.79% | 3.96% | 6.10x | 2.98x | 0.68x | 4.51x | 16.08x | 2.04B | |
| Weighted average by Cap. | 3.3% | 3.88% | 9.62x | 3.13x | 0.77x | 6.55x | 14.70x |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
